Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by jojomarchon Sep 25, 2017 7:07am
91 Views
Post# 26736462

RE:RE:Bremachlorin

RE:RE:BremachlorinGreat post LaserStock and thanks for the refresher on the CBC interview . Last week i e-mailed the Wall Street Journal , this week i will e-mail the Globe and Mail and every week i will e-mail a least one  news medium . This morning i  read all the posts of this weekend  ( took me almost an hour ) and realized that i have learned a lot about cancers in the last 3 years of reading the TLT board . I've  only started posting here after the 3/3 results because i thought we were extremely close to a partnership deal of somekind  . I still think  a deal has been in the works and will be announced but i'm willing to wait . If there is competition out there  (ex: South Korea Study )  well just remember that immunotherapy has hundreds of competitors and big pharma is backing lots of them . Cross your fingers everybody the 180 days cystoscopic analysis will be completed whitin a few weeks . Good luck to all the  TLT clinical trial patients !!!!


Happy monday
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse